Zhao‐Qiu Wu

1.1k total citations
19 papers, 848 citations indexed

About

Zhao‐Qiu Wu is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Zhao‐Qiu Wu has authored 19 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Plant Science. Recurrent topics in Zhao‐Qiu Wu's work include Natural Compound Pharmacology Studies (5 papers), Cancer Cells and Metastasis (5 papers) and Synthesis of Organic Compounds (3 papers). Zhao‐Qiu Wu is often cited by papers focused on Natural Compound Pharmacology Studies (5 papers), Cancer Cells and Metastasis (5 papers) and Synthesis of Organic Compounds (3 papers). Zhao‐Qiu Wu collaborates with scholars based in China, United States and Czechia. Zhao‐Qiu Wu's co-authors include Qinglong Guo, Qidong You, Hong-Yan Gu, Li Zhao, Rong Fu, Tao Lu, Wencong Lv, Na Lu, Li Zhao and Nan Jiang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Science Advances.

In The Last Decade

Zhao‐Qiu Wu

18 papers receiving 839 citations

Peers

Countries citing papers authored by Zhao‐Qiu Wu

Since Specialization

Citations

This map shows the geographic impact of Zhao‐Qiu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao‐Qiu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao‐Qiu Wu more than expected).

Fields of papers citing papers by Zhao‐Qiu Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhao‐Qiu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao‐Qiu Wu. The network helps show where Zhao‐Qiu Wu may publish in the future.

Co-authorship network of co-authors of Zhao‐Qiu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhao‐Qiu Wu. A scholar is included among the top collaborators of Zhao‐Qiu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhao‐Qiu Wu. Zhao‐Qiu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Genetic and pharmacological targeting of Snail inhibits atherosclerosis by relieving intraplaque endothelium dysfunction and associated inflammation 2025 ·Acta Pharmacologica Sinica ·(unknown), (unknown), Li Deng, Jinbo Hu, Mingzhen Chen, Hongwei� Jiang, (unknown), Shentong Fang, Stephen J. Weiss, Jie Liu, Rong Fu, Zhao‐Qiu Wu	0
2	Autophagic degradation of SQSTM1 enables fibroblast activation to accelerate wound healing 2025 ·Autophagy ·(unknown), Xin Gu, Wenshu Li, (unknown), Yiting Xu, Qufu Weı, (unknown), Yunchun Zhao, (unknown), Hu‐Lin Jiang, Zhao‐Qiu Wu, (unknown), Lei Qiang	5
3	A naturally derived small molecule compound suppresses tumor growth and metastasis in mice by relieving p53-dependent repression of CDK2/Rb signaling and the Snail-driven EMT 2024 ·Chinese Journal of Natural Medicines ·(unknown), Yang Li, Lei Di, (unknown), Li‐Juan Liu, Hongmei Li, Yi Li, (unknown), Yong‐Ming Yan, Tao Lu, Rong Fu, Yong‐Xian Cheng, Zhao‐Qiu Wu	2
4	Pharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer 2023 ·British Journal of Pharmacology ·Cheng Li-zhi, (unknown), (unknown), Jiahao Zhang, Ting Xiong, Chen Zhou, Naixia Zhang, Rong Fu, Yong‐Xian Cheng, Zhao‐Qiu Wu	5
5	Structural Optimization and Improving Antitumor Potential of Moreollic Acid from Gamboge 2022 ·Molecules ·Cheng Li-zhi, (unknown), (unknown), Keming Li, Zhao‐Qiu Wu, Yong‐Xian Cheng	1
6	Omeprazole suppresses aggressive cancer growth and metastasis in mice through promoting Snail degradation 2021 ·Acta Pharmacologica Sinica ·Yang Li, (unknown), Hongmei Li, Tao Lu, Rong Fu, Zhao‐Qiu Wu	12
7	The antibiotic drug trimethoprim suppresses tumour growth and metastasis via targeting Snail 2021 ·British Journal of Pharmacology ·(unknown), Yang Li, Hongmei Li, Tao Lu, Zhao‐Qiu Wu, Rong Fu	8
8	A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer 2020 ·Science Advances ·Hongmei Li, (unknown), Li Yang, Rong Fu, Wencong Lv, Nan Jiang, Ying Xu, (unknown), Yadong Chen, Hui Xie, (unknown), Tao Lu, Zhao‐Qiu Wu	40
9	Inactivation of endothelial ZEB1 impedes tumor progression and sensitizes tumors to conventional therapies 2020 ·Journal of Clinical Investigation ·Rong Fu, Yi Li, Nan Jiang, (unknown), (unknown), Lijuan Liu, Wencong Lv, Hongmei Li, Stephen J. Weiss, Zhengyu Li, Tao Lu, Zhao‐Qiu Wu	35
10	Endothelial ZEB1 promotes angiogenesis-dependent bone formation and reverses osteoporosis 2020 ·Nature Communications ·Rong Fu, Wencong Lv, Ying Xu, (unknown), Xiaojie Chen, Nan Jiang, Yan Xu, Qingqiang Yao, Lei Di, Tao Lu, Liming Wang, Ran Mo, Zhao‐Qiu Wu	130
11	Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer 2019 ·Journal of Experimental & Clinical Cancer Research ·Lei Di, Li‐Juan Liu, Yong‐Ming Yan, Rong Fu, Yi Li, Ying Xu, Yong‐Xian Cheng, Zhao‐Qiu Wu	37
12	A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours 2019 ·Nature Communications ·Rong Fu, (unknown), Ting Ni, Lei Di, Li‐Juan Liu, Wencong Lv, (unknown), Nan Jiang, Yin He, Hongmei Li, (unknown), Hui Xie, Baoan Chen, Xiaosheng Wang, Stephen J. Weiss, Tao Lu, Qinglong Guo, Zhao‐Qiu Wu	45
13	LW106, a novel indoleamine 2,3‐dioxygenase 1 inhibitor, suppresses tumour progression by limiting stroma‐immune crosstalk and cancer stem cell enrichment in tumour micro‐environment 2018 ·British Journal of Pharmacology ·Rong Fu, Yiwei Zhang, Hongmei Li, Wencong Lv, Li Zhao, Qinglong Guo, Tao Lu, Stephen J. Weiss, Zhiyu Li, Zhao‐Qiu Wu	43
14	Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation 2015 ·Biochemical Pharmacology ·Yang Sun, Yue Zhao, Jing Yao, Li Zhao, Zhao‐Qiu Wu, Yu Wang, Di Pan, Hanchi Miao, Qinglong Guo, Na Lu	132
15	Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis 2015 ·Oncotarget ·Rong Fu, Yan Chen, Xiaoping Wang, (unknown), (unknown), Yuxin Zhou, Yujie Huang, Baoan Chen, (unknown), Qidong You, Qinglong Guo, Zhao‐Qiu Wu	26
16	General pharmacological properties, developmental toxicity, and analgesic activity of gambogic acid, a novel natural anticancer agent 2009 ·Drug and Chemical Toxicology ·Li Zhao, Zhen Chen, Zhao‐Qiu Wu, Rong Hu, Changlin Zhou, Qinglong Guo	44
17	Reactive oxygen species accumulation contributes to gambogic acid-induced apoptosis in human hepatoma SMMC-7721 cells 2009 ·Toxicology ·Fei-Fei Nie, Xiaonan Zhang, Qi Qi, Lan‐Yan Yang, Yong Yang, Wei Liu, Na Lu, Zhao‐Qiu Wu, Qidong You, Qinglong Guo	83
18	Toxicological Studies of Gambogic Acid and its Potential Targets in Experimental Animals 2006 ·Basic & Clinical Pharmacology & Toxicology ·Qinglong Guo, Qi Qi, Qidong You, Hong-Yan Gu, Li Zhao, Zhao‐Qiu Wu	50
19	Gambogic Acid Inhibits Proliferation of Human Lung Carcinoma SPC-A1 Cells in Vivo and in Vitro and Represses Telomerase Activity and Telomerase Reverse Transcriptase mRNA Expression in the Cells 2004 ·Biological and Pharmaceutical Bulletin ·Zhao‐Qiu Wu, Qinglong Guo, Qidong You, Li Zhao, Hong-Yan Gu	150

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact